Novel mechanisms of diabetic nephropathy

糖尿病肾病的新机制

基本信息

项目摘要

DESCRIPTION (provided by applicant): Energy status of cells is altered by diabetes; its role in diabetes-induced kidney injury is not well studied. Diabetic nephropathy is characterized by renal hypertrophy and extracellular matrix accumulation. mRNA translation, an energy consuming process, is the rate-limiting step in protein synthesis and is a site of regulation even when gene expression is controlled by transcription. However, the role of energy sensors in regulation of mRNA translation underlying diabetes-induced renal hypertrophy and matrix synthesis has not been addressed. We wish to examine the role of an important energy sensor, AMP-activated protein kinase (AMPK), in renal hypertrophy and matrix accumulation. The rationale for these studies is based on the following preliminary data. Phosphorylation of AMPK and its activity are reduced in association with high glucose-induced increase in protein synthesis and hypertrophy, and increase in matrix protein synthesis in renal cells, as well as, in renal cortex and glomeruli of rodents with type 1 or type 2 diabetes at the stage of renal hypertrophy. Administration of metformin and AICAR restores reduced AMPK phosphorylation and inhibits renal hypertrophy seen in the type 1 diabetic rat. However, the role of AMPK in progressive renal injury in type 1 or type 2 diabetes is not known. We wish to test the hypothesis that AMPK activity regulates renal hypertrophy and matrix accumulation in type 1 and type 2 diabetes. Our Specific Aims are: Specific aim 1. In vitro studies. (A) To explore mediators and signaling pathways involved in high glucose regulation of AMPK phosphorylation. Glomerular epithelial, mesangial and proximal tubular epithelial cells in culture will be studied under conditions of hyperglycemia that induce cell hypertrophy, and stimulate mRNA translation and synthesis of matrix proteins. We will investigate if altered AMP-ATP content, activity of LKB-1, an upstream kinase for AMPK, PI 3-kinase-Akt axis, and PKC-TGF-3 axis serve as upstream cues to regulate changes in AMPK phosphorylation and activity. (B) To investigate AMPK regulation of initiation and elongation phases of mRNA translation. The downstream effects of AMPK in regulation of critical events initiation and elongation phases of mRNA translation will be studied; signaling pathways mediating AMPK effect will be elucidated. (C) To explore the role of AMPK in high glucose induced matrix synthesis by renal cells in the context of augmented mRNA translation of matrix proteins. Polyribosomal assays and in vitro translation assays will be employed to define the role of AMPK. Specific aim 2. In vivo studies. To explore role of AMPK in renal pathology in type 1 or type 2 diabetes. Regulation of AMPK phosphorylation by aforementioned upstream factors and its activity and regulation of downstream effectors will be studied in the early stage (4 -14 days) of renal hypertrophy and established stage (3 months) of matrix accumulation and correlated with functional changes in albuminuria and changes in GFR. The ability of AICAR and metformin to inhibit both the anatomical and functional changes induced by diabetes in rodent models of type 1 and type 2 diabetes will be explored. AMPK alphal knock out mice will be studied for evolution of renal abnormalities in type 1 and type 2 diabetes. These studies may identify AMPK as a novel mediator of injury and a treatment target in diabetic nephropathy.
描述(由申请人提供):糖尿病改变了细胞的能量状态;其在糖尿病诱导的肾损伤中的作用尚未得到充分研究。糖尿病肾病的特征是肾脏肥大和细胞外基质积聚。mRNA翻译是一个能量消耗过程,是蛋白质合成的限速步骤,即使基因表达受转录控制,它也是一个调控位点。然而,能量传感器在糖尿病诱导的肾脏肥大和基质合成的基础上的mRNA翻译调节中的作用尚未得到解决。我们希望研究一个重要的能量传感器,AMP激活的蛋白激酶(AMPK),在肾脏肥大和基质积累的作用。这些研究的基本原理基于以下初步数据。AMPK的磷酸化及其活性的降低与高葡萄糖诱导的蛋白质合成和肥大的增加以及肾细胞中基质蛋白合成的增加以及患有1型或2型糖尿病的啮齿动物在肾肥大阶段的肾皮质和肾小球中的基质蛋白合成的增加相关。二甲双胍和AICAR的给药恢复了1型糖尿病大鼠中观察到的降低的AMPK磷酸化并抑制肾脏肥大。然而,AMPK在1型或2型糖尿病进行性肾损伤中的作用尚不清楚。我们希望验证AMPK活性调节1型和2型糖尿病患者肾脏肥大和基质积聚的假设。我们的目标是:具体目标1。体外研究。(A)目的探讨高糖对AMPK磷酸化的调节机制及信号通路。将在诱导细胞肥大并刺激mRNA翻译和基质蛋白合成的高血糖条件下研究培养的肾小球上皮、系膜和近端肾小管上皮细胞。我们将研究AMP-ATP含量的改变、AMPK上游激酶LKB-1的活性、PI 3-激酶-Akt轴和PKC-TGF-3轴是否作为上游信号调节AMPK磷酸化和活性的变化。(B)研究AMPK对mRNA翻译起始和延伸阶段的调控。研究AMPK在mRNA翻译关键事件起始和延伸阶段的下游调控作用,阐明AMPK作用的信号通路。(C)目的探讨AMPK在高糖诱导的肾细胞基质合成中的作用。将采用多核糖体测定和体外翻译测定来确定AMPK的作用。具体目标2。体内研究。探讨AMPK在1型和2型糖尿病肾脏病理中的作用。将在肾脏肥大的早期(4 - 14天)和基质积聚的建立阶段(3个月)研究上述上游因子对AMPK磷酸化的调节及其活性和下游效应物的调节,并与白蛋白尿的功能变化和GFR的变化相关。将探索AICAR和二甲双胍在1型和2型糖尿病啮齿动物模型中抑制糖尿病诱导的解剖学和功能变化的能力。将研究AMPK肾脏敲除小鼠在1型和2型糖尿病中肾脏异常的演变。这些研究可能将AMPK确定为一种新的损伤介质和糖尿病肾病的治疗靶点。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hydrogen sulfide to the rescue in obstructive kidney injury.
  • DOI:
    10.1038/ki.2013.529
  • 发表时间:
    2014-06
  • 期刊:
  • 影响因子:
    19.6
  • 作者:
  • 通讯作者:
Mechanism of VEGF expression by high glucose in proximal tubule epithelial cells.
  • DOI:
    10.1016/j.mce.2009.09.009
  • 发表时间:
    2010-01-15
  • 期刊:
  • 影响因子:
    4.1
  • 作者:
    Feliers, Denis;Kasinath, Balakuntalam S.
  • 通讯作者:
    Kasinath, Balakuntalam S.
Erk in kidney diseases.
  • DOI:
    10.1155/2011/768512
  • 发表时间:
    2011
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Feliers D;Kasinath BS
  • 通讯作者:
    Kasinath BS
HIV-1 promotes renal tubular epithelial cell protein synthesis: role of mTOR pathway.
HIV-1 促进肾小管上皮细胞蛋白质合成:mTOR 通路的作用。
  • DOI:
    10.1371/journal.pone.0030071
  • 发表时间:
    2012
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Rehman,Shabina;Husain,Mohammad;Yadav,Anju;Kasinath,BalakuntalamS;Malhotra,Ashwani;Singhal,PravinC
  • 通讯作者:
    Singhal,PravinC
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BALAKUNTALAM S KASINATH其他文献

BALAKUNTALAM S KASINATH的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BALAKUNTALAM S KASINATH', 18)}}的其他基金

New insights in mechanisms of renal injury
肾损伤机制的新​​见解
  • 批准号:
    8433218
  • 财政年份:
    2012
  • 资助金额:
    $ 25.87万
  • 项目类别:
New insights in mechanisms of renal injury
肾损伤机制的新​​见解
  • 批准号:
    8802851
  • 财政年份:
    2012
  • 资助金额:
    $ 25.87万
  • 项目类别:
New Insights in Mechanisms of Renal Injury
肾损伤机制的新​​见解
  • 批准号:
    9269456
  • 财政年份:
    2012
  • 资助金额:
    $ 25.87万
  • 项目类别:
New insights in mechanisms of renal injury
肾损伤机制的新​​见解
  • 批准号:
    8331647
  • 财政年份:
    2012
  • 资助金额:
    $ 25.87万
  • 项目类别:
New insights in mechanisms of renal injury
肾损伤机制的新​​见解
  • 批准号:
    8698289
  • 财政年份:
    2012
  • 资助金额:
    $ 25.87万
  • 项目类别:
New Insights in Mechanisms of Renal Injury
肾损伤机制的新​​见解
  • 批准号:
    9137229
  • 财政年份:
    2012
  • 资助金额:
    $ 25.87万
  • 项目类别:
Novel mechanisms of diabetic nephropathy
糖尿病肾病的新机制
  • 批准号:
    7315490
  • 财政年份:
    2007
  • 资助金额:
    $ 25.87万
  • 项目类别:
Novel mechanisms of diabetic nephropathy
糖尿病肾病的新机制
  • 批准号:
    7617188
  • 财政年份:
    2007
  • 资助金额:
    $ 25.87万
  • 项目类别:
GLOMERULAR EPITHELIAL CELL METABOLISM IN DIABETES MELLIT
糖尿病的肾小球上皮细胞代谢
  • 批准号:
    3242299
  • 财政年份:
    1990
  • 资助金额:
    $ 25.87万
  • 项目类别:
GLOMERULAR EPITHELIAL CELL METABOLISM IN DIABETES
糖尿病中的肾小球上皮细胞代谢
  • 批准号:
    3242296
  • 财政年份:
    1990
  • 资助金额:
    $ 25.87万
  • 项目类别:

相似海外基金

REU Site: Design, Create, and Innovate 3-Dimensional User Interfaces to Improve Human Sensory and Motor Performance in Virtual Environments (HUMANS MOVE)
REU 网站:设计、创建和创新 3 维用户界面,以提高虚拟环境中的人类感官和运动表现 (HUMANS MOVE)
  • 批准号:
    2349771
  • 财政年份:
    2024
  • 资助金额:
    $ 25.87万
  • 项目类别:
    Standard Grant
CAREER: Atomic-level understanding of stability and transition kinetics of 3-dimensional interfaces under irradiation
职业:对辐照下 3 维界面的稳定性和转变动力学的原子水平理解
  • 批准号:
    2340085
  • 财政年份:
    2024
  • 资助金额:
    $ 25.87万
  • 项目类别:
    Continuing Grant
Artificial fabrication of 3-dimensional noncollinear magnetic order and magnetization manipulation by spin torque
三维非共线磁序的人工制造和自旋转矩磁化操纵
  • 批准号:
    23H00232
  • 财政年份:
    2023
  • 资助金额:
    $ 25.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Understanding of 3-dimensional seismic behavior of RC frame high-speed railway/highway viaducts using FE analysis
使用有限元分析了解 RC 框架高速铁路/公路高架桥的 3 维抗震性能
  • 批准号:
    23H01489
  • 财政年份:
    2023
  • 资助金额:
    $ 25.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Modernization of 3-dimensional printing capabilities at the Aquatic Germplasm and Genetic Resource Center
水产种质和遗传资源中心 3 维打印能力的现代化
  • 批准号:
    10736961
  • 财政年份:
    2023
  • 资助金额:
    $ 25.87万
  • 项目类别:
The 3-dimensional nest of the honey bee: organization, development, and impact on colony function
蜜蜂的 3 维巢穴:组织、发育及其对蜂群功能的影响
  • 批准号:
    2216835
  • 财政年份:
    2023
  • 资助金额:
    $ 25.87万
  • 项目类别:
    Standard Grant
Research on high-density 3-dimensional polymer optical waveguide device for photonics-electronics convergence
光电子融合高密度三维聚合物光波导器件研究
  • 批准号:
    23H01882
  • 财政年份:
    2023
  • 资助金额:
    $ 25.87万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Scaff-Net: 3 Dimensional multiphoton polymerisation printed scaffolds for medium throughput recording from stem cell derived human cortical networks.
Scaff-Net:3 维多光子聚合打印支架,用于从干细胞衍生的人类皮质网络进行中等通量记录。
  • 批准号:
    EP/X018385/1
  • 财政年份:
    2023
  • 资助金额:
    $ 25.87万
  • 项目类别:
    Research Grant
3-dimensional prompt gamma imaging for online proton beam dose verification
用于在线质子束剂量验证的 3 维瞬发伽马成像
  • 批准号:
    10635210
  • 财政年份:
    2023
  • 资助金额:
    $ 25.87万
  • 项目类别:
Equipment: MRI: Track 1 Acquisition of a 3-Dimensional Nanolithography Instrument
设备:MRI:轨道 1 获取 3 维纳米光刻仪器
  • 批准号:
    2320636
  • 财政年份:
    2023
  • 资助金额:
    $ 25.87万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了